Dr. Agarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. MARYLAND
M/C 6038
Chicago, IL 60637Phone+1 773-702-3080- Is this information wrong?
Summary
- Dr. Piyush Agarwal is an urologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Weill Cornell Medicine and has been in practice 17 years. He also speaks multiple languages, including French, Hindi, and Urdu. He specializes in surgical oncology and is experienced in urologic oncology and bladder cancer. He has more than 100 publications and over 500 citings.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2006 - 2008
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2002 - 2006- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 2000 - 2002
Weill Cornell MedicineClass of 2000
Certifications & Licensure
DE State Medical License Current
IL State Medical License 2019 - 2026
IN State Medical License 2023 - 2025
PA State Medical License 2012 - 2021
VA State Medical License 2018 - 2020
MD State Medical License 2014 - 2020
MI State Medical License 2008 - 2015- American Board of Urology Urology
- Join now to see all
Clinical Trials
- Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG Start of enrollment: 2013 Dec 18
- Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) Start of enrollment: 2018 Jun 07
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Necrotizing granulomatous epididymo-orchitis post intravesical BCG administration after brachytherapy for prostate cancer.Aaron Dahmen, Jay K Jhaveri, Alon Lazarovich, David Nusbaum, Quoc-Dien Trinh, Nilesh Gupta, Piyush K Agarwal> ;Urology Case Reports. 2024 May 1
- Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis.Christopher P Dall, James B Mason, Charlotte C Goldman, Grant Fabrizio, Emily C Alagha, Jiling Chou, Keith J Kowalczyk, Piyush K Agarwal, Lambros Stamatakis, Ross E Kr...> ;Urologic Oncology. 2024 May 1
- Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.Lee, B., Smith, A., Lotan, Y., Agarwal, P., Black, P., Dickstein, R., Kamat, A., Narayan, V., Porten, S., Psutka, S., Svatek, R., Williams, S., Woldu, S.> ;Urologic Oncology. 2024 Feb 1
- Join now to see all
Press Mentions
What the Color of Your Pee Can Tell You About Your HealthJanuary 30th, 2021- What the Smell of Your Pee Can Tell You About Your HealthJanuary 23rd, 2021
ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019- Join now to see all
Other Languages
- French, Hindi, Urdu
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
